Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
Venice Servellita, Abdullah M. Syed, Mary Kate Morris, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1539-1548.e5
Open Access | Times Cited: 159

Showing 26-50 of 159 citing articles:

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
Maren Bormann, Leonie Brochhagen, Mira Alt, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Anti-SARS-CoV-2 IgG Seroprevalence in Tyrol, Austria, among 28,768 Blood Donors between May 2022 and March 2023
Anita Siller, Lisa Seekircher, Manfred Astl, et al.
Vaccines (2024) Vol. 12, Iss. 3, pp. 284-284
Open Access | Times Cited: 5
Covalent inhibition of the SARS-CoV-2 NiRAN domain via an active-site cysteine
Genaro Hernandez, Adam Osinski, Abir Majumdar, et al.
Journal of Biological Chemistry (2025), pp. 108378-108378
Open Access
SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasion
Wenjing Ruan, Pengyue Gao, Xiao Qu, et al.
EBioMedicine (2025) Vol. 114, pp. 105634-105634
Closed Access
Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection
Hye Won Jeong, Se‐Mi Kim, Min Kyung Jung, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100764-100764
Open Access | Times Cited: 26
Vaccine breakthrough infection leads to distinct profiles of neutralizing antibody responses by SARS-CoV-2 variant
Michael S. Seaman, Mark J. Siedner, Julie Boucau, et al.
JCI Insight (2022) Vol. 7, Iss. 19
Open Access | Times Cited: 25
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Hadeel T. Zedan, Hadi M. Yassine, Duaa W. Al‐Sadeq, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Neutralising reactivity against SARS-CoV-2 Delta and Omicron variants by vaccination and infection history
Enrico Lavezzo, Monia Pacenti, Laura Manuto, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Systemic immune profiling of Omicron-infected subjects inoculated with different doses of inactivated virus vaccine
Shanhe Yu, Yingni Lin, Yong Li, et al.
Cell (2023) Vol. 186, Iss. 21, pp. 4615-4631.e16
Open Access | Times Cited: 13
A vaccine delivery system promotes strong immune responses against SARS‐CoV‐2 variants
Zhiwei Lei, Leqing Zhu, Pan Pan, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 2
Open Access | Times Cited: 12
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
Shô Miyamoto, Takeshi Arashiro, Akira Ueno, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105969-105969
Open Access | Times Cited: 12
Aptamers dimerization inspired biomimetic clamp assay towards impedimetric SARS-CoV-2 antigen detection
Cong Han, Wenping Xing, Wenjin Li, et al.
Sensors and Actuators B Chemical (2023) Vol. 380, pp. 133387-133387
Open Access | Times Cited: 12
Host Genetic Variation Impacts SARS-CoV-2 Vaccination Response in the Diversity Outbred Mouse Population
Marta C Cruz Cisneros, Elizabeth J. Anderson, Brea K. Hampton, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 103-103
Open Access | Times Cited: 4
Infection-mediated immune response in SARS-CoV-2 breakthrough infection and implications for next-generation COVID-19 vaccine development
Shô Miyamoto, Tadaki Suzuki
Vaccine (2024) Vol. 42, Iss. 6, pp. 1401-1406
Closed Access | Times Cited: 4
SARS-CoV-2 Omicron: Viral Evolution, Immune Evasion, and Alternative Durable Therapeutic Strategies
Hailong Guo, Sha Ha, Jason Botten, et al.
Viruses (2024) Vol. 16, Iss. 5, pp. 697-697
Open Access | Times Cited: 4
Durability of immune responses to SARS-CoV-2 infection and vaccination
Mehul S. Suthar
Seminars in Immunology (2024) Vol. 73, pp. 101884-101884
Closed Access | Times Cited: 4
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105044-105044
Open Access | Times Cited: 21
Neutralization sensitivity, fusogenicity, and infectivity of Omicron subvariants
Xuejun Wang, Lin Yao, Hong‐Yun Zhang, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 19
Humoral immunity for durable control of SARS-CoV-2 and its variants
Ryutaro Kotaki, Saya Moriyama, Yoshimasa Takahashi
Inflammation and Regeneration (2023) Vol. 43, Iss. 1
Open Access | Times Cited: 11
Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?
Ki‐Back Chu, Fu‐Shi Quan
Viruses (2023) Vol. 15, Iss. 2, pp. 392-392
Open Access | Times Cited: 11
Host protection against Omicron BA.2.2 sublineages by prior vaccination in spring 2022 COVID-19 outbreak in Shanghai
Ziyu Fu, Dongguo Liang, Wei Zhang, et al.
Frontiers of Medicine (2023) Vol. 17, Iss. 3, pp. 562-575
Open Access | Times Cited: 11
Omicron infection-associated T- and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals
Joana Barros‐Martins, Swantje I. Hammerschmidt, Gema Morillas Ramos, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Functional dissection of the spike glycoprotein S1 subunit and identification of cellular cofactors for regulation of swine acute diarrhea syndrome coronavirus entry
Yong‐Le Yang, Bin Wang, Wentao Li, et al.
Journal of Virology (2024) Vol. 98, Iss. 4
Open Access | Times Cited: 3
Current immunoassays and detection of antibodies elicited by Omicron SARS‐CoV‐2 infection
Marion Migueres, Sabine Chapuy‐Regaud, Marcel Miédougé, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 16
Tissue immunity to SARS‐CoV‐2: Role in protection and immunopathology*
Ksenia Rybkina, Julia Davis‐Porada, Donna L. Färber
Immunological Reviews (2022) Vol. 309, Iss. 1, pp. 25-39
Open Access | Times Cited: 15

Scroll to top